PETER S. KIM

Insider Reports History

Location
Whitehouse Station, United States
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PETER S. KIM:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. Director Common Stock 117,412 $1,712,677 $14.59 14 May 2024 Direct
Entrada Therapeutics, Inc. Director Stock Option (Right to Buy) 19,000 11 Jun 2025 Direct

Insider Reports Filed by PETER S. KIM

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRDA Entrada Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 08:08
TRDA Entrada Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:38
TRDA Entrada Therapeutics, Inc. 03 Jun 2024 2 +$72,223 4 Director 05 Jun 2024, 16:31
TRDA Entrada Therapeutics, Inc. 14 May 2024 1 +$364,672 4 Director 16 May 2024, 16:33
TRDA Entrada Therapeutics, Inc. 13 May 2024 2 +$731,682 4/A Director 18 Jun 2025, 16:32
TRDA Entrada Therapeutics, Inc. 08 May 2024 2 +$63,306 4 Director 10 May 2024, 16:35
TRDA Entrada Therapeutics, Inc. 08 Apr 2024 1 +$35,290 4 Director 10 Apr 2024, 16:35
TRDA Entrada Therapeutics, Inc. 28 Mar 2024 1 +$20,794 4 Director 01 Apr 2024, 16:31
TRDA Entrada Therapeutics, Inc. 22 Mar 2024 3 +$122,882 4 Director 26 Mar 2024, 17:57
TRDA Entrada Therapeutics, Inc. 19 Mar 2024 3 +$34,996 4 Director 21 Mar 2024, 16:31
TRDA Entrada Therapeutics, Inc. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:05
TRDA Entrada Therapeutics, Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:02
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 1 $0 4 Director 01 Nov 2021, 18:59
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 0 $0 3 Director 28 Oct 2021, 21:03